The pharmaceutical industry is facing major challenges today, linked to the strong rise in temperature-sensitive biotechnology products and tightening regulations.
In just a few short years, cold-chain logistics has become a key issue for the pharmaceutical industry. The temperature-controlled logistics market for healthcare products is expected to reach $13 billion in 2019, a 40% increase on 2013!
High standards for ultra-sensitive products
Our commitment; never break the cold chain for highly sensitive medicines. We have made this promise an absolute priority in our airports.
As a major pharmaceutical hub, Groupe ADP guarantees that it will comply with the highest standards in terms of transport and preservation to protect the integrity of your pharmaceutical products and ensure their timely delivery to any continent in the world.
Our assets:
• 15,000 m² of temperature-controlled spaces
• "CEIV Pharma” certification from the International Air Transport Association (IATA)
8 major air cargo players are already CEIV Pharma certified
6 others are currently in the process of obtaining certification
Want to find out more about
our dedicated facilities?
Contact us